BioSpace News Archive

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) today announced that the new IVD configuration of its Accelerate PhenoTest® BC kit has been CE marked and is ready for use in Europe.

Heska Corporation, a leading provider of advanced veterinary diagnostic and specialty products, reported financial results in two segments for its second quarter ended June 30, 2021.

Silverback Therapeutics, Inc. today announced that the Company will participate in the 2021 Wedbush PacGrow Healthcare Conference from August 10-11, 2021.

NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for medical imaging and therapeutic applications, and GE Healthcare announced the signing of an exclusive agreement for the manufacturing and distribution of iodine-123 capsules in the United States.

Ambrx today announced the first patient has been dosed in a Phase 1, multicenter, open-label, dose-escalation, and dose expansion study to evaluate the safety, pharmacokinetics (PK), and anti-tumor activity of ARX517 in subjects with prostate specific membrane antigen (PSMA).

Aptinyx Inc. today announced that Norbert Riedel, Ph.D., chief executive officer, will participate in the “Brains of the Operation - Novel Approaches in Neuro” panel discussion at the Wedbush PacGrow Healthcare Virtual Conference on Tuesday, August 10 at 12:00 p.m. ET.

Goldfinch Bio today announced that Anthony Johnson, M.D., President and Chief Executive Officer of Goldfinch Bio, will participate in a panel discussion, Casino Re-nal Part 1 – Novel Mechanisms in Renal Disorders , at the Wedbush PacGrow Healthcare Virtual Conference on Tuesday, August 10, 2021.

Alnylam Pharmaceuticals, Inc. today reported its consolidated financial results for the second quarter ended June 30, 2021 and reviewed recent business highlights.

ReCode Therapeutics today announced that Company leadership will host 1x1 meetings at two upcoming virtual investor conferences in August: Canaccord Genuity 41 st Annual Growth Conference. Dates: August 10 – 12, 2021

Biocept has appointed David Karlander as Senior Vice President of Commercial Operations.